Tag: Prescription Drugs
Paxlovid Safe for Pregnant Patients With COVID-19
However, unexpectedly high rate of cesarean deliveries seen in this cohort
SGLT-2i Use Before COVID-19 May Reduce Adverse Outcomes in Diabetes Patients
SGLT-2is associated with lowest probability for adverse outcomes followed by glucagon-like peptide-1 receptor agonists, metformin
Paxlovid Soon Will Not Be Free for Americans
At this point, about 6 million Americans have taken free Paxlovid doses
Study Explores Impact of FDA Approval of Aducanumab on Trial Participation
Individuals who were independently aware of the FDA decision demonstrated reduced willingness to participate
Bromocriptine Quick Release Beneficial for Teens With T1DM
Improvements seen in blood pressure and central and peripheral aortic stiffness and pressure hemodynamics in teens with type 1 diabetes
Dapagliflozin Reduces Hospitalizations Among Patients With CKD
Reduction seen in rate of admissions due to cardiac disorders, renal and urinary disorders, metabolism and nutrition disorders, neoplasms
FDA: No Useful Monoclonal Antibody Treatments Left Against New COVID-19 Variants
Immunocompromised patients can still receive convalescent plasma
Bevacizumab, Aflibercept Compared for Neovascular AMD
At the end of one year, likelihood of being weaned off treatment was higher for eyes treated with aflibercept versus bevacizumab
More Biosimilars Marketed in Germany, Switzerland Than U.S.
Monthly treatment costs of biosimilars were higher in the United States than corresponding costs in Germany, Switzerland
No Significant Association Found for ADHD Meds, CVD Risk
Meta-analysis shows no significant associations for children, adolescents, or adults, for female patients, or for those with preexisting CVD